Kagome has been granted a patent for a powdery food that contains a micronized first powder with myrosinase activity and a second powder containing a glucosinolate. The first powder has a mean volume diameter of not more than 500 µm, while the second powder has no myrosinase activity. GlobalData’s report on Kagome gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Kagome, probiotic culture preservation was a key innovation area identified from patents. Kagome's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11641867B2) describes a powdery food that contains two types of powders. The first powder is micronized and has myrosinase activity, while the second powder contains a glucosinolate but has no myrosinase activity. The mean volume diameter of the first powder is not more than 500 µm, and it can range from 50 to 300 µm.
The first powder in the powdery food can be derived from cruciferous vegetables or seeds of cruciferous vegetables. Cruciferous vegetables are a group of vegetables that includes mustard and broccoli. The second powder can also be derived from cruciferous vegetables or seeds of cruciferous vegetables. In this case, the cruciferous vegetable mentioned is broccoli.
One specific glucosinolate mentioned in the patent is glucoraphanin. Glucosinolates are a group of compounds found in cruciferous vegetables that have been associated with various health benefits.
This patent describes a unique powdery food formulation that combines the myrosinase activity of the micronized first powder with the glucosinolate content of the second powder. Myrosinase is an enzyme that plays a crucial role in the breakdown of glucosinolates into bioactive compounds, such as isothiocyanates, which have been linked to potential health benefits, including anti-cancer properties. By separating the myrosinase activity and glucosinolate content into different powders, the patent aims to optimize the bioavailability and functionality of these compounds in the final product.
The powdery food described in this patent could have potential applications in the food industry, particularly in the development of functional foods or dietary supplements that aim to provide the health benefits associated with cruciferous vegetables. The micronized first powder with myrosinase activity and the second powder containing glucosinolates offer a convenient and versatile way to incorporate these bioactive compounds into various food products. Further research and development may be needed to explore the commercial viability and potential consumer acceptance of this powdery food formulation.
To know more about GlobalData’s detailed insights on Kagome, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
